Upload
deirdre-fields
View
284
Download
4
Embed Size (px)
Citation preview
Tumor Tumor immunotherapyimmunotherapy
张沛张沛 张书铭张书铭
张黎明张黎明 赵宸赵宸 赵世刚赵世刚
Tumour Immunotherapy: Tumour Immunotherapy: questionsquestions
• Can immune stimulators combat cancer?
• Which forms of immunotherapy can be used?
• Is vaccination effective against established tumours?
• Can anti-tumour responses be generated in vitro?
• Can in vitro responses translate into in vivo effects?
• What barriers are there to development of effective IT?
……???
Tumor=DeathTumor=Death??
• Adminstration of monoclonal antibodies which target either tumour-specific or over-expressed antigens.
• Kill tumour cells in a variety of ways:
Apoptosis induction
Complement-mediated
cytotoxicity
ADCC
NKMØ
Conjugated to toxin / isotope
N.o 1 N.o 1 ‘Passive’ immunotherapy ‘Passive’ immunotherapy
STRESSES
HSPs protect the delicate functions of the cell.
N.o 2 Heat Shock Proteins for TherapyN.o 2 Heat Shock Proteins for Therapy
Heat Shock Proteins(HSP70)
NH4COOH
ATPase peptide-binding domain
tumour peptide sequence
APC
TAP systemTransporter Associated with Peptide processingCD91
Hsp70 or gp96 / peptide complex
endocytosisreceptor
CTL
NK
tumour peptides presented to CTL / NK cells via HLA Class I
How is the anti-tumour effect produced?How is the anti-tumour effect produced?
Vaccination using HSP complexesVaccination using HSP complexes
Peripheral blood from CML patient
Isolate HSP complexes from
tumour cellsAPC
Co-culture with patient T cells and expand effectors
for infusion into patient
Load APCwith HSP complexes in vitro
Immunize patient directly with tumour antigen-
primed APC
Heat Shock Proteins(HSP70)
NH4COOH
ATPase peptide-binding domain
tumour peptide sequence
Survival rates in a model of lymphoma
Immunized with PBS ()
40 µg HSP70 from liver ()
20 µg HSP70 A20 cells ()
40 µg HSP70 A20 cells ()
• Dendritic cells are key components of the adaptive immune response ,can activate naive T cell
• APC function with ability to direct IR (activation/tolerance)
• Present in peripheral blood as circulating subtypes (<0.4% TWC)
N.o 3 Dendritic cell therapyN.o 3 Dendritic cell therapy
DC-based therapyDC-based therapy
DC developed from patient monocytes
Pulsed with target antigens
Stimulated to maturation and inoculated back into
patient
Tumour-specific immune responses
measured
Currently in Phase II and Phase III trials for melanoma, prostatic carcinoma and lymphoma.
Dendritic cell sources for therapy
Haemopoietic Stem Cell
Common Myeloid Progenitor
Monocyte
CirculatingMyeloid DC
Immature mdDC
Ex vivo GM-CSF + IL-
4
CD34+Stem Cell
CD34+ DC
Ex vivo GM-CSF +
Flt-3 + TNF
Mature mdDC
Maturation factors
Copland et al (2005) Cancer Immunol. Immunother. 54:297
HSP—peptide complex vaccine HSP—peptide complex vaccine Dendritic cells vaccine Dendritic cells vaccine ------Active immunotherapy ------Active immunotherapy
N.o4 N.o4 Adoptive immunotherapyAdoptive immunotherapy
Definition: Definition: Induce, activate or multiply the anti-Induce, activate or multiply the anti-
tumor effective cells tumor effective cells inin vitrovitro.Then .Then transfuse the cells to thetransfuse the cells to the patients to patients to cause anti-tumor function .cause anti-tumor function .
Common anti-tumor effective cellsCommon anti-tumor effective cells
LAK (lymphokine-activated killers)LAK (lymphokine-activated killers)TIL (tumor infiltrating lymphocytes) :TIL (tumor infiltrating lymphocytes) :higherhigher
specificityspecificityCD3AK (CD3 antibodty activated killers)CD3AK (CD3 antibodty activated killers)CTL cellCTL cell
手术 复发 免疫治疗
肿瘤消失 另一侧新生肿瘤
肿瘤组织减少
N.o 5 Cytokine therapyN.o 5 Cytokine therapy
The mechanism of cytokine therapy for The mechanism of cytokine therapy for tumor is that after being injected into body tumor is that after being injected into body , the cytokine can regulate and , the cytokine can regulate and increase the activity of immune cells ,and increase the activity of immune cells ,and have enhance anti-tumor effect. have enhance anti-tumor effect.
So far, So far, IL-2IL-2,IFN-r,TNF-a and CSF have been ,IFN-r,TNF-a and CSF have been used for tumor treatmentused for tumor treatment . .
N.o 6 N.o 6 Gene therapyGene therapy
Tumor cells may lose some genes or Tumor cells may lose some genes or express abnormal genes . express abnormal genes . Transduce Transduce target genetarget gene to body and restore the to body and restore the function of tumor cells help them to function of tumor cells help them to express normal products.express normal products.
New pathways--gene therapy
Cytokines gene(IL 、 IFN 、 TNF)Tumor Ag gene
MHC gene
Co-stimulatory molecule gene( B7)Tumor suicide gene
anti-oncogene
Tumor ‡ Tumor ‡ DeathDeath
Thank you!
See you!See you!
Common anti-tumor effective cellsCommon anti-tumor effective cells
LAK (lymphokine-activated killers)LAK (lymphokine-activated killers)TIL (tumor infiltrating lymphocytes) :TIL (tumor infiltrating lymphocytes) :higherhigher
specificityspecificityCD3AK (CD3 antibodty activated killers)CD3AK (CD3 antibodty activated killers)CTL cellCTL cell